|
|
|
|
| LEADER |
00000nam a2200000 4500 |
| 008 |
220208b xxu||||| |||| 00| 0 eng d |
| 999 |
|
|
|c 408321
|d 408321
|
| 100 |
|
|
|a Wattamwar Tejas Baboo
|9 46845
|
| 245 |
|
|
|a Method Development, Validation and In-Vivo Bioequivalence Studies of Anti-Diabetic Drugs
|
| 260 |
|
|
|a Mumbai
|b NMIMS-SOS
|c 2021
|
| 300 |
|
|
|a 343
|
| 502 |
|
|
|a 1-CD (Incomplete Data)
|b Ph.D
|c NMIMS-SDSoS
|d 2021
|
| 504 |
|
|
|a Pandita Nancy
|
| 650 |
|
|
|a In-Vivo Bioequivalence Studies
|a Anti-Diabetic Drugs
|9 46846
|
| 720 |
|
|
|a Pandita Nancy
|
| 952 |
|
|
|0 0
|1 0
|2 ddc
|4 0
|7 0
|9 471706
|a 00004532
|b 00004532
|d 2022-02-08
|l 0
|p SBMPH292
|r 2022-02-08
|w 2022-02-08
|y PH
|